glp 1 drugs and kidney function GLP-1 receptor agonists in patients with chronic disease either overweight or obesity Updated evidence on cardiovascular and
Description
Physician check-ins remain important
Research continues to investigate their safety and efficacy for the treatment of substance use disorders
There is no doubt that obesity is one of the world's greatest health problems, and the World Health Organisation is clear that this is truly an epidemic
Here, the incidence rate in studies was very low and the study data have shown different results, so that further research is warranted on this observation
